‘Two-in-one’ boob job uses unwanted body fat

London, Sep 14 (ANI): Here’s some news that will bring double joy to women: a “two in one” boob job technique that uses unwanted fat from other parts of the body has been developed.

The breast enlargement operation takes excess fat from the thighs and stomach and moves it to the bust.

The pioneering technique has been tested in Britain and the U.S. and is expected to be offered to British women by early next year.

And it is believed that the effects are “astounding”, resulting in larger breasts that look and feel just like normal as no implant has been introduced into the body.

Experts have predicted that the procedure, which might cost around 8,000 pounds, will eventually overtake implants to dominate the cosmetic surgery market.

According to the Harley Medical Group, the technique has originated from reconstructive surgery and was tested in Britain after a 10-year study on global developments in fat grafting.

They said that the results experienced by patients in the US and UK, who had the procedure four or five years ago, have shown that the effects are lasting.

Two of the Harley Medical Group’s surgeons have now been trained in the procedure in the US, while eight more surgeons are set to join them before the end of this year.

“This is the most exciting breakthrough in cosmetic and reconstructive surgery that I have seen over the last two decades,” The Daily Express quoted chairman Mel Braham as saying.

“Following some final reviews by our medical board, we should be in a position to launch this procedure in the UK early next year,” Braham added.

Dr Zdenek Pros, a consultant surgeon trained in the procedure, said: “This type of augmentation technique is very effective in enabling surgeons to shape the breast and achieve smooth, natural-looking contours.” (ANI)

Human trial of stem cell therapy for stroke patients begins in UK

Washington, Jan 19 (ANI): Taking a revolutionary step in stem cell research, scientists in the UK will be injecting stem cells into patients to try to repair brain damage in stroke patients.

For the first time, scientists will take stem cells from an aborted foetus and inject them into the brain of stroke victims.

If successful, the trial could put British scientists at the forefront of research into incurable diseases.
The scientists are hoping that cells, which can renew themselves, will regenerate areas damaged by stroke, and increase patients’ movements and mental abilities.

However, pro-life groups have described the advance as “sick,” saying it is unethical to use aborted foetuses.

In the trial, four groups of three patients will be given the treatment over the next two years, starting with a low dose of two million foetal stem cells and rising to 20 million.

“If it works, as it has done in animal model systems, it may allow new nerve cells to grow or regeneration of existing cells and actual recovery of function in patients who would not otherwise be able to regain function,” The Telegraph quoted Dr Keith Muir, the consultant surgeon leading the trial at the Southern General Hospital in Glasgow, as saying.

He added: “You can reorganise the brain, you can help that reorganisation with physiotherapy but you cannot cause new nerve cells to grow. The hope with stem cell therapy is that by putting in new cells and new tissue that you can further improve on that recovery.

“Europe is going to be the centre in stem cells and regenerative medicine and that is very exciting.”

The Society for the Unborn Child described the proposal as “sick”, saying it involved “cannibalising an unborn child”. (ANI)